Form 4 for KYNB KYNTRA BIO, INC.
Accepted 2023-03-29 00:00:00 ET · period of report 2023-03-20 · accession 0001209191-23-021539 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-29 | 2023-03-20 | KYNB | Wettig Thane | Chief Commercial Off | G - Gift | $0.00 | -2,343 | 108.3K | -2% | $0 | |
| I | 2023-03-29 | 2023-03-20 | KYNB | Wettig Thane | Chief Commercial Off | G - Gift | $0.00 | +1,000 | 1,000 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-20 | G | D | 2,343 | $0.00 | 108,310 | D By spouse | — | — | (F1) The share total in column 5 reflects ownership as of March 28, 2023. |
| 2 | Common | Common Stock | 2023-03-20 | G | A | 1,000 | $0.00 | 1,000 | I | — | — | (F1) The share total in column 5 reflects ownership as of March 28, 2023. |